Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Filing Details

Accession Number:
0001144204-15-058275
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-10-06 16:09:10
Reporting Period:
2015-10-05
Filing Date:
2015-10-06
Accepted Time:
2015-10-06 16:09:10
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1527599 Mirna Therapeutics Inc. MIRN Pharmaceutical Preparations (2834) 261824804
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1245624 James Healy 3000 Sand Hill Road, 4-250
Menlo Park CA 94025
No No Yes No
1253170 Srinivas Akkaraju 3000 Sand Hill Road, 4-250
Menlo Park CA 94025
No No Yes No
1524064 Sofinnova Venture Partners Viii, L.p. Sofinnova Ventures
3000 Sand Hill Road, 4-250
Menlo Park CA 94025
No No Yes No
1559565 Sofinnova Management Viii, L.l.c. 3000 Sand Hill Road, 4-250
Menlo Park CA 94025
No No Yes No
1590102 Anand Mehra 3000 Sand Hill Road, 4-250
Menlo Park CA 94025
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2015-10-05 1,244,269 $0.00 1,244,269 No 4 C Direct
Common Stock Acquisiton 2015-10-05 583,559 $0.00 1,827,828 No 4 C Direct
Common Stock Acquisiton 2015-10-06 289,841 $0.00 2,117,669 No 4 J Direct
Common Stock Acquisiton 2015-10-06 857,142 $7.00 2,974,811 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 C Direct
No 4 C Direct
No 4 J Direct
No 4 P Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Series C Preferred Stock Disposition 2015-10-05 1,244,269 $0.00 1,244,269 $0.00
Common Stock Series D Preferred Stock Disposition 2015-10-05 583,559 $0.00 583,559 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 No 4 C Direct
0 No 4 C Direct
Footnotes
  1. Each share of Series C and Series D Preferred Stock automatically converted on a one-to-one basis into Common Stock immediately prior to the consummation of the Issuer's initial public offering.
  2. The shares are held by Sofinnova Venture Partners VIII, L.P. ("SVP VIII"). Sofinnova Management VIII, L.L.C. ("SM VIII") is the general partner of SVP VIII. The individual Managers, or the Managing Members, of SM VIII are Michael Powell, James Healy, Srinivas Akkaraju and Anand Mehra. The Managers share voting and dispositive power with regard to the shares held directly by SVP VIII. Such persons and entities disclaim beneficial ownership over the shares owned by SVP VIII except to the extent of any pecuniary interest therein.
  3. The shares were issued for no additional consideration pursuant to an accruing paid-in-kind dividend on shares of Series C and Series D Preferred Stock of the Company.
  4. The expiration date is not relevant to the conversion of the securities.
  5. Due to a clerical error, the Reporting Persons' Form 3 which previously reported the holding of these shares understated his total by one (1) share.